Improving Intracellular Doxorubicin Delivery Through Nanoliposomes Equipped with Selective Tumor Cell Membrane Permeabilizing Short-Chain Sphingolipids
Lília R. Cordeiro Pedrosa, Gerben A. Koning(Università Cattolica del Sacro Cuore), Wiggert A. van Cappellen(Erasmus MC), Regine Süss(University of Freiburg), Albert J. van Hell, Timo L.M. ten Hagen(Erasmus MC), Ann L.B. Seynhaeve(Rotterdam University of Applied Sciences), Alexander Eggermont(University Medical Center Utrecht), Wim J. van Blitterswijk(The Netherlands Cancer Institute), Marcel Verheij(Radboud University Nijmegen)
Cited by 19
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
TNF-α in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility
|The Oncologist|2006|711
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589